Catherine Schulte
Stock Analyst at Baird
(3.38)
# 935
Out of 4,760 analysts
120
Total ratings
54.37%
Success rate
12.63%
Average return
Main Sectors:
Stocks Rated by Catherine Schulte
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Maintains: Outperform | $161 → $159 | $121.90 | +30.43% | 15 | Feb 27, 2025 | |
| MRVI Maravai LifeSciences Holdings | Downgrades: Neutral | $9 → $3 | $2.86 | +4.90% | 5 | Feb 26, 2025 | |
| TECH Bio-Techne | Downgrades: Neutral | $88 → $68 | $62.90 | +8.11% | 10 | Feb 19, 2025 | |
| QGEN Qiagen | Downgrades: Neutral | $52 → $42 | $38.89 | +8.00% | 3 | Feb 19, 2025 | |
| MTD Mettler-Toledo International | Maintains: Neutral | $1,362 → $1,369 | $1,294.40 | +5.76% | 7 | Feb 10, 2025 | |
| DHR Danaher | Maintains: Outperform | $268 → $258 | $205.23 | +25.71% | 7 | Jan 30, 2025 | |
| EXAS Exact Sciences | Maintains: Outperform | $70 → $67 | $44.97 | +48.99% | 13 | Nov 6, 2024 | |
| AVTR Avantor | Maintains: Outperform | $27 → $26 | $17.28 | +50.46% | 10 | Oct 28, 2024 | |
| TMO Thermo Fisher Scientific | Maintains: Outperform | $632 → $622 | $526.80 | +18.07% | 25 | Oct 24, 2024 | |
| CSTL Castle Biosciences | Maintains: Outperform | $42 → $38 | $18.93 | +100.74% | 7 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $56 → $33 | $36.71 | -10.11% | 3 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $335 → $281 | $85.97 | +226.86% | 7 | Sep 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $208 → $217 | $390.29 | -44.40% | 7 | Oct 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $17 → $20 | $132.63 | -84.92% | 1 | Jun 28, 2018 |
Agilent Technologies
Feb 27, 2025
Maintains: Outperform
Price Target: $161 → $159
Current: $121.90
Upside: +30.43%
Maravai LifeSciences Holdings
Feb 26, 2025
Downgrades: Neutral
Price Target: $9 → $3
Current: $2.86
Upside: +4.90%
Bio-Techne
Feb 19, 2025
Downgrades: Neutral
Price Target: $88 → $68
Current: $62.90
Upside: +8.11%
Qiagen
Feb 19, 2025
Downgrades: Neutral
Price Target: $52 → $42
Current: $38.89
Upside: +8.00%
Mettler-Toledo International
Feb 10, 2025
Maintains: Neutral
Price Target: $1,362 → $1,369
Current: $1,294.40
Upside: +5.76%
Danaher
Jan 30, 2025
Maintains: Outperform
Price Target: $268 → $258
Current: $205.23
Upside: +25.71%
Exact Sciences
Nov 6, 2024
Maintains: Outperform
Price Target: $70 → $67
Current: $44.97
Upside: +48.99%
Avantor
Oct 28, 2024
Maintains: Outperform
Price Target: $27 → $26
Current: $17.28
Upside: +50.46%
Thermo Fisher Scientific
Oct 24, 2024
Maintains: Outperform
Price Target: $632 → $622
Current: $526.80
Upside: +18.07%
Castle Biosciences
Mar 1, 2023
Maintains: Outperform
Price Target: $42 → $38
Current: $18.93
Upside: +100.74%
Nov 21, 2022
Maintains: Outperform
Price Target: $56 → $33
Current: $36.71
Upside: -10.11%
Sep 22, 2020
Maintains: Neutral
Price Target: $335 → $281
Current: $85.97
Upside: +226.86%
Oct 30, 2019
Maintains: Neutral
Price Target: $208 → $217
Current: $390.29
Upside: -44.40%
Jun 28, 2018
Maintains: Outperform
Price Target: $17 → $20
Current: $132.63
Upside: -84.92%